Background In the phase 2 multicohort CheckMate 142 study (NCT02060188), nivolumab plus low-dose (1 mg/kg) ipilimumab provided robust and durable clinical benefit with a manageable safety...
Purpose: To determine the safety and feasibility of filling an abdominal aortic aneurysm (AAA) sac with a novel, bioabsorbable embolic device at the time as endovascular aneurysm repair (...